Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels. Our drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach to treat a broad range of diseases. Our focus is on developing drugs to treat cancer including novel, small molecule immuno-oncology agents.
View Top Employees from Nurix TherapeuticsWebsite | http://www.nurixtx.com |
Ticker | NRIX |
Revenue | $39.2 million |
Funding | $354.1 million |
Employees | 306 (306 on RocketReach) |
Founded | 2012 |
Address | 1700 Owens Street Suite 205, San Francisco, California 94158, US |
Phone | (415) 660-5320 |
Fax | (415) 525-4200 |
Technologies |
JavaScript,
HTML,
PHP
+39 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare |
Web Rank | 10 Million |
Keywords | Small Molecule Drug Discovery |
Competitors | Ascentage Pharma, C4 Therapeutics, Inc., Scholar Rock, TCR² Therapeutics Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 2833 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 541 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Nurix Therapeutics employee's phone or email?
The Nurix Therapeutics annual revenue was $39.2 million in 2024.
Eren Demirhan is the Vice President, Head of Biometrics of Nurix Therapeutics.
306 people are employed at Nurix Therapeutics.
Nurix Therapeutics is based in San Francisco, California.
The NAICS codes for Nurix Therapeutics are [54, 325, 32, 541, 32541, 3254].
The SIC codes for Nurix Therapeutics are [283, 28, 2833, 87].